Stansbury Ellsworth, a 59-year-old female with NIDDM, GERD, HTN, Depression, and known CAD s/p circumflex stent 2002, was admitted with atypical chest pain. Her EKG showed NSR 79 bpm, normal axis and intervals, with 1 mm ST segment depression V3-V5, and inverted Ts in V3-V5. Her CXR was negative for effusions, infiltrates, edema, and normal bony structures. A Mibi on 10/22 showed small perfusion defect without reversibility. Her esophagitis responded quickly to KBL and DIFLUCAN with her tolerating PO on AM of discharge. She was prescribed CLONAZEPAM 0.5 MG PO QD, LISINOPRIL 5 MG PO QD, POTASSIUM CHLORIDE IV, POTASSIUM CHLORIDE PO, MOM (MAGNESIUM HYDROXIDE) 30 MILLILITERS PO QD, MAALOX-TABLETS QUICK DISSOLVE/CHEWABLE 1-2 TAB PO Q6H, PROTONIX (PANTOPRAZOLE) 40 MG PO QD, LIPITOR (ATORVASTATIN) 20 MG PO QHS, ATENOLOL 25 MG PO QD, ECASA (ASPIRIN ENTERIC COATED) 81 MG PO QD, REMERON (MIRAZAPINE) 15 MG PO QHS, CELEXA (CITALOPRAM) 20 MG PO QD, METFORMIN 500 MG PO BID, DIFLUCAN (FLUCONAZOLE) 100 MG PO QD X 12 doses, and KCL IMMEDIATE RELEASE PO. Overrides were added for DIFLUCAN PO (ref #62332050) and KCL IMMEDIATE RELEASE PO (ref # 57130577) due to POTENTIALLY SERIOUS INTERACTIONS: CLONAZEPAM & FLUCONAZOLE and LISINOPRIL & POTASSIUM CHLORIDE, respectively. She was to continue with remeron, celexa, and clonazepam, and was prescribed MAALOX-TABLETS QUICK DISSOLVE/CHEWABLE 1-2 TAB PO Q6H PRN Upset Stomach, and MOM (MAGNESIUM HYDROXIDE) 30 MILLILITERS PO QD Starting Today (9/4) PRN Constipation, Upset Stomach. She will complete two-week course of FLUCONAZOLE, with consideration of an outpatient EGD if symptoms do not improve with treatment. She was discharged in stable condition.
diflucan ( fluconazole )
DIFLUCAN (FLUCONAZOLE) 100 MG PO QD X 12 doses,